Oman oncology department to reduce foreign referrals:
This article was originally published in Clinica
Oman has included a state-of-the-art oncology centre in its sixth five-year health plans. The centre, to be constructed at the Royal Hospital in Muscat, is aimed at cutting the number of referrals abroad for cancer patients. At present, up to 68% of patients are forced to go abroad for treatment, Omani health minister Ali bin Mohammed bin Moosa told The Oman Times.
You may also be interested in...
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.
Executives On The Move: Comings And Goings At Atara Biothera And Pfizer, Along With A Promotion At Domainex
T-cell immunotherapy firm Atara Biotherapeutics decides on a chief commercial officer and Pfizer oncology R&D head leaves for CSO spot at Vividion Therapeutics. Also, COO of UK drug discovery CRO Domainex is set to climb to CEO position.